Emflaza oral suspension — Cigna
Duchenne muscular dystrophy in patients age ≥ 2 years
Preferred products
- generic deflazacort tablets
Initial criteria
- Patient meets the standard Muscular Dystrophy – Deflazacort Prior Authorization Policy criteria; AND
- Patient meets ONE of the following (i or ii):
- i. Patient has tried generic deflazacort tablets [documentation required]; OR
- ii. Patient cannot swallow or has difficulty swallowing tablets
Approval duration
1 year